Description

Imidazo[1,2-A]Pyrazin-3(7H)-One, 6-[4-(Acetyloxy)Phenyl]-2-[[4-(Acetyloxy)Phenyl]Methyl]-8-(Phenylmethyl)- is a sophisticated heterocyclic organic compound with a complex molecular architecture, serving as a critical advanced pharmaceutical intermediate or research chemical. Its value lies in its unique structural framework, which is essential for synthesizing novel bioactive molecules and exploring new chemical spaces in medicinal chemistry. This compound is primarily needed by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing new therapeutic agents and high-value specialty chemicals.

Application

This specialized chemical serves as a key building block in advanced synthetic pathways. Its primary applications include:

• Pharmaceutical Intermediate: Core scaffold for the synthesis of novel drug candidates targeting various disease pathways.
• Medicinal Chemistry Research: Used in hit-to-lead optimization and structure-activity relationship (SAR) studies to develop new active pharmaceutical ingredients (APIs).
• Biochemical Probe Development: Serves as a precursor for creating molecular tools to study biological processes and enzyme functions.
• Fine Chemical Synthesis: A valuable intermediate in the multi-step production of complex, high-value specialty chemicals.
• Academic & Institutional Research: Utilized in universities and research institutes for exploratory chemistry and the development of new synthetic methodologies.

Basic Information

Product Name	Imidazo[1,2-A]Pyrazin-3(7H)-One, 6-[4-(Acetyloxy)Phenyl]-2-[[4-(Acetyloxy)Phenyl]Methyl]-8-(Phenylmethyl)-
CAS No.	65417-18-7
Molecular Formula	C31H26N2O5
Molecular Weight	506.55 g/mol
Synonyms	6-[4-(Acetyloxy)phenyl]-2-[[4-(acetyloxy)phenyl]methyl]-8-(phenylmethyl)imidazo[1,2-a]pyrazin-3(7H)-one; 2,6-Bis(4-acetoxyphenyl)-8-benzyl-imidazo[1,2-a]pyrazin-3-one; 65417-18-7; Imidazo[1,2-a]pyrazin-3(7H)-one, 6-[4-(acetyloxy)phenyl]-2-[[4-(acetyloxy)phenyl]methyl]-8-(phenylmethyl)-; 8-Benzyl-2,6-bis(4-hydroxyphenyl)imidazo[1,2-a]pyrazin-3(7H)-one diacetate
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management protocols. Every batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing all specifications are provided with each shipment. We operate under a quality system designed to meet the exacting standards of pharmaceutical R&D and cGMP environments where applicable.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). This compound may be light-sensitive and should be handled accordingly to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.